Followers | 39 |
Posts | 2870 |
Boards Moderated | 0 |
Alias Born | 12/06/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 29, 2005 7:53:50 AM
Surely he can sell just ONE product to one customer!
I am shocked you have not heard of BSX. Rather large customer.
Biotechs can easily command billion dollar market caps long before they ever get to market. The path to market through regulatory authorities is a long and treacherous one but the rewards can more than compensate with a guaranteed monopoly enforced by the feds.
Why ignore the realities of the marketplace?
For now, Biophan's products are IP.
Intangibles are quite salable.
What price would you put on, say, just the name Coca-Cola, Jagman? Some have put a rather hefty price on it. The sugar and water product is rather cheap by comparison.
Best, Terry
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM